Pulmatrix (PULM) FCF Margin (QoQ) (2014 - 2024)
Pulmatrix (PULM) FCF Margin (QoQ) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5.87 Mn |
| Sep 30, 2024 | -42,851.00 |
| Jun 30, 2024 | -21,970.00 |
| Mar 31, 2024 | 599.00 |
| Dec 31, 2023 | 21,935.00 |
| Sep 30, 2023 | -2,942.00 |
| Jun 30, 2023 | 12,134.00 |
| Mar 31, 2023 | -6,963.00 |
| Dec 31, 2022 | -8,188.00 |
| Sep 30, 2022 | 13,651.00 |
| Jun 30, 2022 | 18,273.00 |
| Mar 31, 2022 | 43,922.00 |
| Dec 31, 2021 | -65,056.00 |
| Sep 30, 2021 | -2,974.00 |
| Jun 30, 2021 | 10,588.00 |
| Mar 31, 2021 | -25,277.00 |
| Dec 31, 2020 | -1,412.00 |
| Sep 30, 2020 | 1,443.00 |
| Jun 30, 2020 | -16,827.00 |
| Mar 31, 2020 | 28,904.00 |